237 related articles for article (PubMed ID: 32735195)
1. State Laws Governing Syringe Services Programs and Participant Syringe Possession, 2014-2019.
Fernández-Viña MH; Prood NE; Herpolsheimer A; Waimberg J; Burris S
Public Health Rep; 2020; 135(1_suppl):128S-137S. PubMed ID: 32735195
[TBL] [Abstract][Full Text] [Related]
2. State syringe and drug possession laws potentially influencing safe syringe disposal by injection drug users.
Burris S; Welsh J; Ng M; Li M; Ditzler A
J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S94-8. PubMed ID: 12489625
[TBL] [Abstract][Full Text] [Related]
3. Syringe services programs: An examination of legal, policy, and funding barriers in the midst of the evolving opioid crisis in the U.S.
Jones CM
Int J Drug Policy; 2019 Aug; 70():22-32. PubMed ID: 31059965
[TBL] [Abstract][Full Text] [Related]
4. The legality of selling or giving syringes to injection drug users.
Burris S; Vernick JS; Ditzler A; Strathdee S
J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S13-8. PubMed ID: 12489604
[TBL] [Abstract][Full Text] [Related]
5. State laws, syringe exchange, and HIV among persons who inject drugs in the United States: History and effectiveness.
Bramson H; Des Jarlais DC; Arasteh K; Nugent A; Guardino V; Feelemyer J; Hodel D
J Public Health Policy; 2015 May; 36(2):212-30. PubMed ID: 25590514
[TBL] [Abstract][Full Text] [Related]
6. Access to Syringe Services Programs - Kentucky, North Carolina, and West Virginia, 2013-2017.
Bixler D; Corby-Lee G; Proescholdbell S; Ramirez T; Kilkenny ME; LaRocco M; Childs R; Brumage MR; Settle AD; Teshale EH; Asher A
MMWR Morb Mortal Wkly Rep; 2018 May; 67(18):529-532. PubMed ID: 29746453
[TBL] [Abstract][Full Text] [Related]
7. Barriers to engaging people who use drugs in harm reduction services during the COVID-19 pandemic: A mixed methods study of syringe services program perspectives.
Austin EJ; Corcorran MA; Briggs ES; Frost MC; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Jarlais DCD; Williams EC; Glick SN
Int J Drug Policy; 2022 Nov; 109():103825. PubMed ID: 35977459
[TBL] [Abstract][Full Text] [Related]
8. "They don't go by the law around here": law enforcement interactions after the legalization of syringe services programs in North Carolina.
Morrissey B; Hughes T; Ostrach B; Wilson L; Getty R; Combs TL; Bennett J; Carroll JJ
Harm Reduct J; 2022 Sep; 19(1):106. PubMed ID: 36163255
[TBL] [Abstract][Full Text] [Related]
9. Shifting the paradigm: physician-authorized, student-led efforts to provide harm reduction services amidst legislative opposition.
McMullen TP; Naeim M; Newark C; Oliphant H; Suchard J; Banimahd F
Subst Abuse Treat Prev Policy; 2021 Mar; 16(1):27. PubMed ID: 33761954
[TBL] [Abstract][Full Text] [Related]
10. Police officer attitudes towards syringe services programming.
Sightes E; Ray B; Paquet SR; Bailey K; Huynh P; Weintraut M
Drug Alcohol Depend; 2019 Dec; 205():107617. PubMed ID: 31707271
[TBL] [Abstract][Full Text] [Related]
11. Vaccination barriers and opportunities at syringe services programs in the United States, June-August 2021-A cross-sectional survey.
Montgomery MP; Zhong Y; Roberts E; Asher A; Bixler D; Doshani M; Christensen A; Eckert M; Weng MK; Carry M; Samuel CR; Teshale EH
Drug Alcohol Depend; 2022 Aug; 237():109540. PubMed ID: 35753280
[TBL] [Abstract][Full Text] [Related]
12. Access to HIV, Viral Hepatitis, and Substance Use Disorder Treatment/Overdose Prevention Services: A Qualitative Analysis of Syringe Service Programs (SSPs) Serving Rural PWID.
Carnes NA; Asher AK; Bohm MK; Bessler PA
Subst Use Misuse; 2021; 56(13):1933-1940. PubMed ID: 34353216
[TBL] [Abstract][Full Text] [Related]
13. Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US.
Taussig JA; Weinstein B; Burris S; Jones TS
AIDS; 2000 Jun; 14 Suppl 1():S47-51. PubMed ID: 10981474
[TBL] [Abstract][Full Text] [Related]
14. High street prices of syringes correlate with strict syringe possession laws.
Rich JD; Foisie CK; Towe CW; McKenzie M; Salas CM
Am J Drug Alcohol Abuse; 2000 Aug; 26(3):481-7. PubMed ID: 10976670
[TBL] [Abstract][Full Text] [Related]
15. Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020.
Behrends CN; Lu X; Corry GJ; LaKosky P; Prohaska SM; Glick SN; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC
Drug Alcohol Depend; 2022 Mar; 232():109323. PubMed ID: 35124386
[TBL] [Abstract][Full Text] [Related]
16. Syringe access and health harms: Characterizing "landscapes of antagonism" in California's Central Valley.
Syvertsen JL; Pollini RA
Int J Drug Policy; 2020 Jan; 75():102594. PubMed ID: 31775079
[TBL] [Abstract][Full Text] [Related]
17. Distributive Syringe Sharing and Use of Syringe Services Programs (SSPs) Among Persons Who Inject Drugs.
Adams M; An Q; Broz D; Burnett J; Wejnert C; Paz-Bailey G;
AIDS Behav; 2019 Dec; 23(12):3306-3314. PubMed ID: 31512066
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Syringe Services Program Policy on Risk Behaviors Among Persons Who Inject Drugs in 3 US Cities, 2005-2015.
Nassau T; Al-Tayyib A; Robinson WT; Shinefeld J; Brady KA
Public Health Rep; 2020; 135(1_suppl):138S-148S. PubMed ID: 32735193
[TBL] [Abstract][Full Text] [Related]
19. Weathering the Storm: Syringe Services Program Laws and Human Immunodeficiency Virus During the COVID-19 Pandemic.
Jackson H; Dunphy C; Grist MB; Jiang X; Xu L; Guy GP; Salvant-Valentine S
J Acquir Immune Defic Syndr; 2023 Dec; 94(5):395-402. PubMed ID: 37949442
[TBL] [Abstract][Full Text] [Related]
20. Factors that influence enrollment in syringe services programs in rural areas: a qualitative study among program clients in Appalachian Kentucky.
Ibragimov U; Cooper KE; Batty E; Ballard AM; Fadanelli M; Gross SB; Klein EM; Lockard S; Young AM; Cooper HLF
Harm Reduct J; 2021 Jun; 18(1):68. PubMed ID: 34193165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
